Alejandro DLS,Mateu A,Gorostidi M,Vinyoles E,Segura J,Ruilope LM .2021 .Antihypertensive therapy and short-term blood pressure variability. J. Hypertens, 39(2) : 349-355.
Fan SH,Chen HS,Chen SX,Hou XL .2018 .Study on the correlation between 137 cases of perimenopausal hypertension and traditional Chinese medicine physique. Hebei J. Trad. Chin. Med, 40(5) : 55-50.
Kang J,Zhao XS,Ding YN .2015 .The effect of blood pressure variability on carotid atherosclerosis in elderly women with hypertension. Chin. J. Geriatric. Cardiovascul. Cerebrovascul. Dis., 17(2) : 200-202.
Khalid AM,Mohammed N,Ahmed EO,Sherif R .2018 .Electrochemical determination of amlodipine besilate and benazepril hydrochloride in their binary mixture using pvc and coated graphite sensors. Int. J. Sci., 5(4) : 28-32.
Schumacher H Ley L .2013 .Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients). Curr. Med. Res. Opin., 29(1) : 41-53.
Li Z Li J .2018 .Research progress in traditional Chinese and Western medicine on the pathogenesis of perimenopausal hypertension. Hunan J. Trad. Chin. Med, 34(3) : 182-184.
Li M,Jin LL .2019 .Observation on the clinical efficacy of TCM treatment of female menopausal hypertension from liver differentiation. J. Guangzhou Univ. Trad. Chin. Med, 36(4) : 30-34.
Li W and Li G .2018 .Key points of Chinese expert consensus on diagnosis and treatment of elderly hypertension (2017 Edition). Chin. J. Hypert., 26(10) : 986-989.
Liu JM .2017 .Modified erxian decoction in the treatment of 86 cases of perimenopausal hypertension. Yunnan J. Trad. Chin Med, 38(5) : 51-52.
Majnaric LT,Martinovi I,Abanovi E,Rudan S,Wittlinger T,Martinovic I,Sefket Šabanovic,Stjepan R,Frantisek B,Thomas W .2019 .The effect of hypertension duration and the age of onset on CV risk factors expression in perimenopausal women. Int. J. Hypertens., : 1-9.
Ning F .2020 .Evaluation of the effect of health education based on the information of wisdom and medicine on the management of patients with essential hypertension. Medical Diet and Health, 18(7) : 182-184.
Shi YJ,Qian WD .2019 .Research progress of traditional Chinese and western medicine on female menopausal hypertension. Xinjiang. Trad. Chin. Med, 183(5) : 80-82.
Song SJ .2018 .Qingxuan jiangya decoction combined with irbesartan in the treatment of 30 cases of perimenopausal essential hypertension. Chin National Folk Med, 27(11) : 109-111.
Sverre K,Giuseppe M,Roland S,Michaela M,Thomas U .2013 .An update on telmisartan/ hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors. Expert. Rev. Cardiovasc. Ther., 11(6) : 673-682.
Tian ZX .2018 .The effect of Qingxuan jiangya decoction combined with western medicine treatment on blood pressure and blood lipids in patients with simple hypertension of yin deficiency and yang hyperactivity. Sichuan. Trad. Chin. Med, 36(10) : 86-89.
Zhang JN,Yang CH .2017 .Modified erxian decoction in the treatment of female menopausal hypertension. J. Integrated Trad. Chin. West Med, 15(16) : 2066-2067.
Zheng XY .2021 .Guidelines for clinical research on new traditional Chinese medicines [M]. China Med, : .